{"id":"administration-of-vancomycin","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Nephrotoxicity"},{"rate":"1-5","effect":"Ototoxicity"},{"rate":"10-15","effect":"Red man syndrome (flushing, pruritus)"},{"rate":"5-10","effect":"Phlebitis at infusion site"},{"rate":"5","effect":"Fever"},{"rate":"5","effect":"Chills"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Vancomycin is a glycopeptide antibiotic that binds to the D-alanyl-D-alanine terminus of peptidoglycan precursors in bacterial cell walls, blocking the cross-linking of peptidoglycan strands. This disrupts cell wall integrity and leads to bacterial cell lysis and death. It is bactericidal and particularly effective against gram-positive organisms.","oneSentence":"Vancomycin inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala peptide precursors and preventing peptidoglycan cross-linking.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:26:46.961Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Serious infections caused by susceptible strains of methicillin-resistant Staphylococcus aureus (MRSA)"},{"name":"Clostridium difficile-associated diarrhea and colitis"},{"name":"Endocarditis caused by susceptible streptococci or staphylococci"},{"name":"Septicemia caused by susceptible gram-positive cocci"}]},"trialDetails":[{"nctId":"NCT02694458","phase":"NA","title":"Comparison of Two Dosage Adjustment Strategies of Vancomycin in Children","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-02-23","conditions":"Methicillin-resistant Staphylococcal Infections","enrollment":100},{"nctId":"NCT07495150","phase":"NA","title":"Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis","status":"NOT_YET_RECRUITING","sponsor":"yilong Wang","startDate":"2026-04-01","conditions":"Blood-Brain Barrier, Bacterial Meningitis","enrollment":86},{"nctId":"NCT06748144","phase":"PHASE2, PHASE3","title":"IO Vancomycin Spine","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-05","conditions":"Lumbar Fusion Surgery","enrollment":30},{"nctId":"NCT06293352","phase":"NA","title":"Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2024-08-08","conditions":"Prosthetic-joint Infection, Knee Infection, Arthroplasty Complications","enrollment":153},{"nctId":"NCT07490054","phase":"PHASE1","title":"Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Melana Yuzefpolskaya, MD","startDate":"2025-09-01","conditions":"Chronic Heart Failure","enrollment":40},{"nctId":"NCT04948463","phase":"PHASE4","title":"Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2021-11-15","conditions":"Febrile Neutropenia","enrollment":55},{"nctId":"NCT06567808","phase":"PHASE4","title":"Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial","status":"NOT_YET_RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2026-03-01","conditions":"Infection, Surgical Site","enrollment":38000},{"nctId":"NCT07300553","phase":"PHASE2","title":"Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-01-02","conditions":"IBD, Crohn Disease, Ulcerative Colitis (UC)","enrollment":45},{"nctId":"NCT05615844","phase":"PHASE3","title":"Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2023-11-05","conditions":"Open tíbia Fracture","enrollment":312},{"nctId":"NCT06889701","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants","status":"RECRUITING","sponsor":"TenNor Therapeutics Inc.","startDate":"2025-04-03","conditions":"Periprosthetic Joint Infection (PJI)","enrollment":33},{"nctId":"NCT04597008","phase":"PHASE3","title":"Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2021-05-11","conditions":"Post Operative Surgical Site Infection","enrollment":1550},{"nctId":"NCT06306014","phase":"PHASE1, PHASE2","title":"Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-05-07","conditions":"Clostridioides Difficile Infection, Recurrent Infection","enrollment":56},{"nctId":"NCT06272994","phase":"NA","title":"Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2024-04-03","conditions":"Community-acquired Pneumonia","enrollment":277},{"nctId":"NCT07435051","phase":"PHASE3","title":"Prospective, Randomized, Multicenter Clinical Trial of Bisphosphonates Combined With Vancomycin for the Treatment of Cierny-Mader Type I and III Osteomyelitis","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-05-01","conditions":"Osteomyelitis (Refractory)","enrollment":280},{"nctId":"NCT06637332","phase":"PHASE4","title":"Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia","status":"RECRUITING","sponsor":"Todd C. Lee MD MPH FIDSA","startDate":"2024-11-14","conditions":"Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia, S. Aureus Bacteremia","enrollment":300},{"nctId":"NCT04075526","phase":"PHASE1","title":"Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2019-10-01","conditions":"Osteoarthritis","enrollment":2129},{"nctId":"NCT06582264","phase":"PHASE1","title":"A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis","status":"COMPLETED","sponsor":"Microbiotica Ltd","startDate":"2024-09-27","conditions":"Ulcerative Colitis","enrollment":29},{"nctId":"NCT06954129","phase":"PHASE4","title":"A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-01-28","conditions":"Acute Kidney Injury","enrollment":750},{"nctId":"NCT04731025","phase":"PHASE3","title":"Local Antibiotics for Breast Implants","status":"RECRUITING","sponsor":"Mikkel Herly","startDate":"2021-01-27","conditions":"Implant Complication, Implant Infection, Implant Site Infection","enrollment":1003},{"nctId":"NCT02701608","phase":"PHASE3","title":"Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-02-29","conditions":"Infective Endocarditis","enrollment":162},{"nctId":"NCT02701595","phase":"PHASE3","title":"Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-02-29","conditions":"Infective Endocarditis","enrollment":324},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT06002607","phase":"","title":"Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2023-12-28","conditions":"Necrotizing Soft Tissue Infection","enrollment":50},{"nctId":"NCT07017946","phase":"PHASE1, PHASE2","title":"Intestinal Microbiome Transplant in ALS","status":"RECRUITING","sponsor":"Duke University","startDate":"2026-01-27","conditions":"Amyotrophic Lateral Sclerosis ALS","enrollment":20},{"nctId":"NCT07376889","phase":"PHASE4","title":"Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia","status":"NOT_YET_RECRUITING","sponsor":"Intermountain Health Care, Inc.","startDate":"2026-02-01","conditions":"Staphylococcus Aureus Bacteremia","enrollment":2096},{"nctId":"NCT04793152","phase":"NA","title":"Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC","status":"RECRUITING","sponsor":"Anthony Bai","startDate":"2023-03-20","conditions":"MRSA","enrollment":700},{"nctId":"NCT03283878","phase":"PHASE4","title":"Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial","status":"COMPLETED","sponsor":"Duke University","startDate":"2017-10-24","conditions":"Arthropathy of Knee, Antibiotic Prophylaxis","enrollment":1770},{"nctId":"NCT04666948","phase":"PHASE4","title":"Precision Dosing of Vancomycin in Critically Ill Children","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2020-12-28","conditions":"Vancomycin","enrollment":314},{"nctId":"NCT07084129","phase":"PHASE1","title":"Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2026-04","conditions":"Sepsis","enrollment":20},{"nctId":"NCT06970262","phase":"NA","title":"FMT for Lung and Associated-organ Rescue Efficacy in Pulmonary Infection With MDROs","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-05-20","conditions":"Lung Infection, Microbial Colonization, Food Intolerance Syndromes","enrollment":150},{"nctId":"NCT07221708","phase":"PHASE2, PHASE3","title":"Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2026-03-01","conditions":"Clostridioides Difficile, Vancomycin Resistance Enterococcus Faecium","enrollment":200},{"nctId":"NCT07283068","phase":"NA","title":"IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-02-15","conditions":"Revision Total Knee Arthroplasty","enrollment":40},{"nctId":"NCT04729322","phase":"PHASE2","title":"Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-22","conditions":"Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8","enrollment":15},{"nctId":"NCT05370885","phase":"PHASE2","title":"VE202 in Patients With Mild-to-Moderate Ulcerative Colitis","status":"TERMINATED","sponsor":"Vedanta Biosciences, Inc.","startDate":"2023-05-08","conditions":"Ulcerative Colitis, Colitis, Ulcerative","enrollment":114},{"nctId":"NCT07282782","phase":"PHASE4","title":"A Prospective, Randomized Parallel Group Study of the Efficacy of Vancomycin Administered Through Intraarticular Injection Versus Intraosseous Injection Versus Intravenous Infusion in Patients Undergoing Total Knee Arthroplasty","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-06-10","conditions":"Total Knee Arthroplasty","enrollment":30},{"nctId":"NCT04138706","phase":"PHASE3","title":"Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2020-11-19","conditions":"Clostridium Difficile Infection","enrollment":263},{"nctId":"NCT06602245","phase":"","title":"Clearance of Antibacterial Agents During Hemoperfusion in Patients With Sepsis","status":"COMPLETED","sponsor":"Efferon JSC","startDate":"2024-10-21","conditions":"Sepsis, Septic Shock","enrollment":30},{"nctId":"NCT01543334","phase":"","title":"Antibiotic Concentrations Among Critically Ill Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2012-03","conditions":"Administration of Antibiotics in Intensive Care Units","enrollment":98},{"nctId":"NCT02284126","phase":"PHASE3","title":"Topical Vancomycin for Neurosurgery Wound Prophylaxis","status":"COMPLETED","sponsor":"Columbia University","startDate":"2014-10","conditions":"Infection, Surgery, Nervous System Diseases","enrollment":1103},{"nctId":"NCT04208958","phase":"PHASE1, PHASE2","title":"Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer","status":"COMPLETED","sponsor":"Vedanta Biosciences, Inc.","startDate":"2020-01-23","conditions":"Metastatic Cancer, Melanoma, Gastric Cancer","enrollment":56},{"nctId":"NCT05137119","phase":"PHASE4","title":"Staphylococcus Aureus Network Adaptive Platform Trial","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2022-02-16","conditions":"Staphylococcus Aureus Bacteremia","enrollment":8000},{"nctId":"NCT06884748","phase":"EARLY_PHASE1","title":"Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy","status":"NOT_YET_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2025-12-01","conditions":"Clostridioides Difficile Infection","enrollment":30},{"nctId":"NCT07204522","phase":"","title":"Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-09-22","conditions":"Febrile Neutropenia","enrollment":20},{"nctId":"NCT07201987","phase":"PHASE2","title":"Intraoperative Placement of Vancomycin-impregnated Calcium Sulfate Beads Conjugated With Analgesics to Improve Spine Surgery Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Ganesh M. Shankar","startDate":"2026-01","conditions":"Spine Surgery, Postoperative Pain Management","enrollment":100},{"nctId":"NCT06540391","phase":"PHASE1","title":"A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Microbiotica Ltd","startDate":"2024-08-28","conditions":"Melanoma","enrollment":41},{"nctId":"NCT04630847","phase":"PHASE1","title":"Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders","status":"NOT_YET_RECRUITING","sponsor":"ProgenaBiome","startDate":"2025-12","conditions":"Autism, Autism Spectrum Disorder","enrollment":10},{"nctId":"NCT05831774","phase":"PHASE4","title":"IO Vancomycin in TSA","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-06-01","conditions":"Shoulder Injuries","enrollment":33},{"nctId":"NCT06443502","phase":"PHASE3","title":"A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis","status":"RECRUITING","sponsor":"Takeda","startDate":"2024-11-19","conditions":"Pouchitis","enrollment":30},{"nctId":"NCT05975671","phase":"NA","title":"Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2023-08-21","conditions":"Sepsis, Sepsis Mrsa, Sepsis Bacteremia","enrollment":52500},{"nctId":"NCT02504554","phase":"PHASE1, PHASE2","title":"Beneficial Bacteria Treatment for Autism","status":"COMPLETED","sponsor":"Arizona State University","startDate":"2014-07","conditions":"Gastrointestinal Problems, Autism Spectrum Disorders","enrollment":18},{"nctId":"NCT05695261","phase":"PHASE2","title":"Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients","status":"RECRUITING","sponsor":"Rima Rachid","startDate":"2023-06-08","conditions":"Allergy, Peanut, Peanut Allergy, Peanut Hypersensitivity","enrollment":37},{"nctId":"NCT07120490","phase":"NA","title":"STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-10","conditions":"Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, Fecal Microbiota Transplantation (FMT)","enrollment":424},{"nctId":"NCT06383611","phase":"","title":"Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Osteal Therapeutics, Inc.","startDate":"","conditions":"Prosthetic-joint Infection","enrollment":""},{"nctId":"NCT07107477","phase":"PHASE3","title":"TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden","status":"RECRUITING","sponsor":"The Central and Eastern European Gynecologic Oncology Group","startDate":"2025-05-01","conditions":"Preterm Premature Rupture of Membranes (PPROM)","enrollment":138},{"nctId":"NCT03935828","phase":"PHASE2","title":"Effect of Topical Sinonasal Antibiotics","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, San Diego","startDate":"2019-06","conditions":"Chronic Rhinosinusitis (Diagnosis), Antibiotic Side Effect","enrollment":""},{"nctId":"NCT05169229","phase":"PHASE2, PHASE3","title":"Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.","status":"RECRUITING","sponsor":"University Hospital, Linkoeping","startDate":"2022-04-01","conditions":"Arthroplasty, Replacement, Hip, Osteoarthritis, Hip, Antibiotic Resistant Infection","enrollment":1100},{"nctId":"NCT04017468","phase":"PHASE2","title":"Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2019-10-15","conditions":"Surgical Site Infection","enrollment":450},{"nctId":"NCT06647277","phase":"PHASE1","title":"Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease","status":"NOT_YET_RECRUITING","sponsor":"ProgenaBiome","startDate":"2026-07","conditions":"Parkinson Disease","enrollment":10},{"nctId":"NCT07013552","phase":"NA","title":"Oritavancin for CIED Infections With MDR Gram-positive Cocci","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-06","conditions":"Cardiac Implantable Electronic Device Infections, Infective Endocarditis, Multidrug-resistant Bacteria Screening","enrollment":100},{"nctId":"NCT04878718","phase":"","title":"Vancomycin and Fecal Microbiota Transplant in a Single Patient With Autism Spectrum Disorder","status":"NO_LONGER_AVAILABLE","sponsor":"ProgenaBiome","startDate":"","conditions":"Autism Spectrum Disorder, Autism","enrollment":""},{"nctId":"NCT05835206","phase":"PHASE2","title":"Further MT for Antibiotic-Resistant Bacterial Colonization in Inpatients","status":"RECRUITING","sponsor":"Emory University","startDate":"2024-04-25","conditions":"Multi-drug Resistant Organism","enrollment":40},{"nctId":"NCT06640491","phase":"PHASE1, PHASE2","title":"Intraosseous (IO) Cefazolin and Vancomycin in Primary Total Knee Arthroplasty (TKA)","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2025-05-15","conditions":"Total Knee Arthroplasty","enrollment":40},{"nctId":"NCT05950984","phase":"","title":"Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)","status":"COMPLETED","sponsor":"St George's, University of London","startDate":"2023-10-30","conditions":"Infection, Bacterial, Antibiotic Side Effect, Antibiotic Resistant Infection","enrollment":30},{"nctId":"NCT04911270","phase":"NA","title":"Clinical Decision Support Tool for Vancomycin Dosing in Children","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2022-05-09","conditions":"Gram-Positive Bacterial Infections, Vancomycin, Pharmacokinetics","enrollment":75},{"nctId":"NCT06967376","phase":"EARLY_PHASE1","title":"The Role of Adjuvant Corneal Crosslinking in the Management of Infective Keratitis","status":"COMPLETED","sponsor":"Research Institute of Ophthalmology, Egypt","startDate":"2018-05-21","conditions":"Infective Keratitis","enrollment":40},{"nctId":"NCT04678154","phase":"PHASE3","title":"Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT","status":"RECRUITING","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2021-05-07","conditions":"Post Operative Surgical Site Infection","enrollment":1200},{"nctId":"NCT05225558","phase":"PHASE2","title":"A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia","status":"TERMINATED","sponsor":"LigaChem Biosciences, Inc.","startDate":"2022-04-26","conditions":"MRSA Bacteremia","enrollment":40},{"nctId":"NCT06197308","phase":"EARLY_PHASE1","title":"Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2024-03-01","conditions":"Primary Sclerosing Cholangitis","enrollment":28},{"nctId":"NCT06895252","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Ulcerative Colitis (UC)","enrollment":220},{"nctId":"NCT06890650","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Crohn Disease","enrollment":168},{"nctId":"NCT06906445","phase":"NA","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences","startDate":"2025-03-15","conditions":"Ulcerative Colitis","enrollment":220},{"nctId":"NCT04077996","phase":"NA","title":"Treatment of Peritonitis in Automated Peritoneal Dialysis","status":"COMPLETED","sponsor":"Universidad de Colima","startDate":"2019-07-01","conditions":"Secondary Peritonitis","enrollment":64},{"nctId":"NCT03713528","phase":"PHASE4","title":"Can Intraosseous Antibiotics Improve the Results of Irrigation & Debridement and Prosthetic Retention for PJI?","status":"ENROLLING_BY_INVITATION","sponsor":"OrthoCarolina Research Institute, Inc.","startDate":"2020-01-14","conditions":"Joint Infection","enrollment":100},{"nctId":"NCT06879184","phase":"","title":"Cohort of the Specialist Network Infectious Diseases","status":"NOT_YET_RECRUITING","sponsor":"Goethe University","startDate":"2025-03-20","conditions":"Infectious Diseases and Manifestations","enrollment":15000},{"nctId":"NCT04042233","phase":"PHASE4","title":"Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol","status":"COMPLETED","sponsor":"The Methodist Hospital Research Institute","startDate":"2019-12-31","conditions":"Prosthetic Joint Infection, Vancomycin, Joint Diseases","enrollment":23},{"nctId":"NCT02285140","phase":"NA","title":"Prevention of Infections in Cardiac Surgery","status":"TERMINATED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2015-04","conditions":"Thoracic Surgery, Antibiotic Prophylaxis","enrollment":5989},{"nctId":"NCT03402945","phase":"PHASE4","title":"Prevention of Infections in Cardiac Surgery (PICS) Prevena Study","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2018-03-05","conditions":"Surgical Site Infections","enrollment":4107},{"nctId":"NCT05141903","phase":"","title":"Dietary Supplement With and Without a Probiotic and/or Antibiotic","status":"COMPLETED","sponsor":"Prolacta Bioscience","startDate":"2021-09-21","conditions":"Healthy Adults","enrollment":92},{"nctId":"NCT04899115","phase":"PHASE2","title":"VE303 for Treatment of Hepatic Encephalopathy (HE)","status":"COMPLETED","sponsor":"Patricia Bloom","startDate":"2021-08-06","conditions":"Cirrhosis, Hepatic Encephalopathy","enrollment":19},{"nctId":"NCT06814223","phase":"PHASE4","title":"Using Antibiotics to Prevent Infections in Hemodialysis Patients During Catheter Placement","status":"RECRUITING","sponsor":"Western Galilee Hospital-Nahariya","startDate":"2024-10-28","conditions":"Infection Catheter-Related","enrollment":200},{"nctId":"NCT05338008","phase":"NA","title":"Intrawound Administration of Vancomycin in THA","status":"COMPLETED","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2022-05-01","conditions":"Hip","enrollment":120},{"nctId":"NCT06384651","phase":"PHASE4","title":"Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2024-12-03","conditions":"Infections, Ankle Arthritis","enrollment":40},{"nctId":"NCT06543940","phase":"NA","title":"Pharmacokinetics Vancomycin CVVHDF with OXiris Membrane","status":"RECRUITING","sponsor":"Mahidol University","startDate":"2024-09-01","conditions":"AKI - Acute Kidney Injury","enrollment":8},{"nctId":"NCT05929599","phase":"NA","title":"Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Children's Hospital, Vietnam","startDate":"2023-07-05","conditions":"Acute Respiratory Tract Infections, Pneumonia, Respiratory Syncytial Virus (RSV)","enrollment":120},{"nctId":"NCT04247542","phase":"PHASE2","title":"ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Acurx Pharmaceuticals Inc.","startDate":"2020-03-06","conditions":"Clostridium Difficile Infection","enrollment":53},{"nctId":"NCT03845790","phase":"PHASE1","title":"Pharmacokinetic Study of Vancomycin, Clindamycin And/or Gentamicin Administration During Surgery Using a Microdialysis Procedure","status":"COMPLETED","sponsor":"Poitiers University Hospital","startDate":"2019-05-26","conditions":"Surgical Site Infection","enrollment":25},{"nctId":"NCT05607030","phase":"PHASE2","title":"A Second Trial of the Abbreviated Protocol Two-Stage Exchange","status":"COMPLETED","sponsor":"Osteal Therapeutics, Inc.","startDate":"2023-01-23","conditions":"Prosthetic-joint Infection","enrollment":76},{"nctId":"NCT05320068","phase":"PHASE3","title":"Oral Vancomycin Vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection","status":"COMPLETED","sponsor":"Julia Orígüen","startDate":"2022-08-02","conditions":"Clostridioides Difficile Infection","enrollment":24},{"nctId":"NCT04775953","phase":"PHASE2","title":"DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-04-22","conditions":"Staphylococcal Bacteraemia","enrollment":200},{"nctId":"NCT05812820","phase":"NA","title":"Effects of Probiotic in Treatment of Persistent Diarrhea in Children","status":"COMPLETED","sponsor":"National Children's Hospital, Vietnam","startDate":"2022-07-01","conditions":"Diarrhea","enrollment":165},{"nctId":"NCT03839914","phase":"NA","title":"Evaluating the Efficacy and Safety of Intra-wound Vancomycin Powder in High Risk Patients","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2020-08-01","conditions":"Spinal Deformity, Trauma, Spinal Tumor","enrollment":76},{"nctId":"NCT06661772","phase":"","title":"Influencing Factors of Vancomycin Trough Level in Critically Ill Children With Sepsis","status":"COMPLETED","sponsor":"Benha University","startDate":"2024-06-01","conditions":"Critically Ill Children, Sepsis","enrollment":160},{"nctId":"NCT04769895","phase":"PHASE3","title":"MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"MaaT Pharma","startDate":"2022-03-25","conditions":"Acute Graft Versus Host Disease in Intestine, Steroid Refractory GVHD","enrollment":66},{"nctId":"NCT04995653","phase":"PHASE1","title":"A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT","status":"COMPLETED","sponsor":"Seres Therapeutics, Inc.","startDate":"2021-11-24","conditions":"Allogeneic Hematopoietic Stem Cell Transplantation","enrollment":60},{"nctId":"NCT06503978","phase":"PHASE2","title":"Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gut-Brain-Axis Therapeutics Inc.","startDate":"2024-08-20","conditions":"Autism Spectrum Disorder, Gastro-Intestinal Disorder, Constipation","enrollment":60},{"nctId":"NCT03796650","phase":"PHASE3","title":"Fecal Transplantation for Primary Clostridium Difficile Infection","status":"TERMINATED","sponsor":"Oslo University Hospital","startDate":"2019-07-17","conditions":"Clostridium Difficile Infection","enrollment":104},{"nctId":"NCT06504992","phase":"PHASE4","title":"Powdered Intrawound Vancomycin in Open Fractures Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Manitoba","startDate":"2024-11-01","conditions":"Open Fracture, Trauma, Infection, Surgical Site","enrollment":350},{"nctId":"NCT02814916","phase":"PHASE3","title":"Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA","status":"COMPLETED","sponsor":"AbbVie","startDate":"2017-03-30","conditions":"Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections","enrollment":199},{"nctId":"NCT04132427","phase":"PHASE2","title":"MTT for Children With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders","status":"COMPLETED","sponsor":"Arizona State University","startDate":"2019-09-30","conditions":"Pitt Hopkins Syndrome","enrollment":6},{"nctId":"NCT06539663","phase":"PHASE2, PHASE3","title":"The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients","status":"COMPLETED","sponsor":"Farwaniya Hospital","startDate":"2022-04-10","conditions":"Corneal Perforation, Exposure Keratitis, Infectious Keratitis","enrollment":5}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Vancomycin Hydrochloride"],"phase":"marketed","status":"active","brandName":"Administration of Vancomycin","genericName":"Administration of Vancomycin","companyName":"University of Colorado, Denver","companyId":"university-of-colorado-denver","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vancomycin inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala peptide precursors and preventing peptidoglycan cross-linking. Used for Serious infections caused by susceptible strains of methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile-associated diarrhea and colitis, Endocarditis caused by susceptible streptococci or staphylococci.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}